130 related articles for article (PubMed ID: 6442697)
1. Normalization of thyroid stimulating hormone levels in acromegalic patients after selective adenomectomy.
Tsuchiya H; Onishi T; Mori S; Lee S; Kohno H; Imanaka S; Saitoh Y; Mogami H; Uozumi T; Kumahara Y
Endocrinol Jpn; 1984 Dec; 31(6):687-95. PubMed ID: 6442697
[TBL] [Abstract][Full Text] [Related]
2. The influence of diabetes mellitus on thyrotropin response to thyrotropin-releasing hormone in untreated acromegalic patients.
Shigemasa C; Abe K; Taniguchi S; Mitani Y; Ueta Y; Adachi T; Urabe K; Tanaka T; Yoshida A; Hori T
J Endocrinol Invest; 1988 Apr; 11(4):231-7. PubMed ID: 3137252
[TBL] [Abstract][Full Text] [Related]
3. Effects of repetitive administration of thyrotropin-releasing hormone at short intervals in acromegaly.
Losa M; Alba-Roth J; Sobieszczyk S; Schopohl J; Müller OA; von Werder K
Acta Endocrinol (Copenh); 1989 Mar; 120(3):383-9. PubMed ID: 2494827
[TBL] [Abstract][Full Text] [Related]
4. Prolactin secretion in acromegalic patients before and after selective adenomectomy.
Tsuchiya H; Onishi T; Takamoto S; Imanaka S; Saitoh Y; Mogami H; Mori S; Uozumi T; Kumahara Y
J Clin Endocrinol Metab; 1985 Jul; 61(1):104-9. PubMed ID: 3923026
[TBL] [Abstract][Full Text] [Related]
5. Preserved thyroidal secretion of thyroxine in acromegalic patients with suppressed hypophyseal secretion of thyrotrophin.
Yoshinari M; Tokuyama T; Kuroda T; Sato K; Okazawa K; Mizokami T; Okamura K; Fujishima M
Clin Endocrinol (Oxf); 1992 Apr; 36(4):355-60. PubMed ID: 1424168
[TBL] [Abstract][Full Text] [Related]
6. The pituitary-thyroid axis in acromegaly.
Eskildsen PC; Kruse A; Kirkegaard C
Horm Metab Res; 1988 Dec; 20(12):755-7. PubMed ID: 3146541
[TBL] [Abstract][Full Text] [Related]
7. Changes in basal and stimulated TSH and other parameters of thyroid function in acromegaly after transsphenoidal surgery.
Geelhoed-Duijvestijn PH; Bussemaker JK; Roelfsema F
Acta Endocrinol (Copenh); 1989 Aug; 121(2):207-15. PubMed ID: 2505466
[TBL] [Abstract][Full Text] [Related]
8. Low serum free thyroxine index in ambulating elderly is due to a resetting of the threshold of thyrotropin feedback suppression.
Lewis GF; Alessi CA; Imperial JG; Refetoff S
J Clin Endocrinol Metab; 1991 Oct; 73(4):843-9. PubMed ID: 1653784
[TBL] [Abstract][Full Text] [Related]
9. Hyperthyroidism caused by a pituitary thyrotrophin-secreting tumour with excessive secretion of thyrotrophin-releasing hormone and subsequently followed by Graves' disease in a middle-aged woman.
Kamoi K; Mitsuma T; Sato H; Yokoyama M; Washiyama K; Tanaka R; Arai O; Takasu N; Yamada T
Acta Endocrinol (Copenh); 1985 Nov; 110(3):373-82. PubMed ID: 3934894
[TBL] [Abstract][Full Text] [Related]
10. The pituitary-thyroid axis in patients with pituitary disorders.
Eskildsen PC; Kruse A; Kirkegaard C
Horm Metab Res; 1989 Jul; 21(7):387-90. PubMed ID: 2506120
[TBL] [Abstract][Full Text] [Related]
11. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.
Arafah BM
J Clin Endocrinol Metab; 1986 Jun; 62(6):1173-9. PubMed ID: 3009521
[TBL] [Abstract][Full Text] [Related]
12. Effects of treatment with octreotide in acromegalic patients--a multicenter Italian study. Italian Multicenter Octreotide Study Group.
Arosio M; Macchelli S; Rossi CM; Casati G; Biella O; Faglia G
Eur J Endocrinol; 1995 Oct; 133(4):430-9. PubMed ID: 7581966
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic effects of octreotide on thyroid axis in growth hormone-secreting and clinically non-functioning pituitary adenomas.
Colao A; Merola B; Ferone D; Marzullo P; Cerbone G; Longobardi S; Di Somma C; Lombardi G
Eur J Endocrinol; 1995 Aug; 133(2):189-94. PubMed ID: 7655643
[TBL] [Abstract][Full Text] [Related]
14. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
Kaplan MM; Taft JA; Reichlin S; Munsat TL
J Clin Endocrinol Metab; 1986 Oct; 63(4):808-14. PubMed ID: 3091628
[TBL] [Abstract][Full Text] [Related]
15. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
[TBL] [Abstract][Full Text] [Related]
16. Lipid metabolism in acromegalic patients before and after selective pituitary adenomectomy.
Tsuchiya H; Onishi T; Mogami H; Iida M
Endocrinol Jpn; 1990 Dec; 37(6):797-807. PubMed ID: 2129301
[TBL] [Abstract][Full Text] [Related]
17. Endocrine, biochemical, and morphological studies of a pituitary adenoma secreting growth hormone, thyrotropin (TSH), and alpha-subunit: evidence for secretion of TSH with increased bioactivity.
Beck-Peccoz P; Piscitelli G; Amr S; Ballabio M; Bassetti M; Giannattasio G; Spada A; Nissim M; Weintraub BD; Faglia G
J Clin Endocrinol Metab; 1986 Apr; 62(4):704-11. PubMed ID: 2419356
[TBL] [Abstract][Full Text] [Related]
18. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
[TBL] [Abstract][Full Text] [Related]
19. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors.
Seo H; Refetoff S; Fang VS
Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of patients with thyrotropin-secreting pituitary adenoma.
Wu YY; Chang HY; Lin JD; Chen KW; Huang YY; Jung SM
J Formos Med Assoc; 2003 Mar; 102(3):164-71. PubMed ID: 12783133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
